Skip to content
Search

Latest Stories

Community pharmacy delivers record-breaking 3 million flu jabs in eight weeks

Smashing all previous records, community pharmacies in England have administered over three million flu vaccinations in just eight weeks since the start of the service in September.

Going by rate at which community pharmacy has delivered this vital public health service so far, the Pharmaceutical Services Negotiating Committee (PSNC) reckons this season pharmacies could be on track to breach the four million annual flu vaccinations mark.


The previous best for the sector was in 2020/21 when it administered 2.76 million vaccines under the national Flu Vaccination Service from 1 September 2020 to 31 March 2021.

Data from PharmOutcomes and Sonar Informatics has confirmed that this year pharmacy teams have already administered over three million vaccinations since 1 September when the 2021/22 service commenced.

PSNC says the total number of vaccinations administered will be even higher as some pharmacy teams have not used the electronic systems to record administration of vaccines.

The statistics can be viewed here.

Commenting on the record figures, PSNC Director of NHS Services Alastair Buxton said: “We’ve been watching the flu vaccination numbers tick up over the past eight weeks and to hit the three million mark this early in the season is an amazing achievement. Doing this in any year would be impressive, but  to do so while we are still in a pandemic, alongside all of the other pressures community pharmacy is currently facing, is a truly remarkable result.

"Thanks go to all community pharmacy contractors and their teams, and LPCs, for working so hard to yet again make the service an outstanding success. As ever, community pharmacy is showing how well it can rise to a challenge – yet another record performance delivering a critical public health service.”

Community pharmacy has been providing flu vaccinations under a nationally commissioned service since September 2015.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less